Literature DB >> 21041410

The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.

Yael Aylon1, Yaara Ofir-Rosenfeld, Norikazu Yabuta, Eleonora Lapi, Hiroshi Nojima, Xin Lu, Moshe Oren.   

Abstract

Apoptosis is an important mechanism to eliminate potentially tumorigenic cells. The tumor suppressor p53 plays a pivotal role in this process. Many tumors harbor mutant p53, but others evade its tumor-suppressive effects by altering the expression of proteins that regulate the p53 pathway. ASPP1 (apoptosis-stimulating protein of p53-1) is a key mediator of the nuclear p53 apoptotic response. Under basal conditions, ASPP1 is cytoplasmic. We report that, in response to oncogenic stress, the tumor suppressor Lats2 (large tumor suppressor 2) phosphorylates ASPP1 and drives its translocation into the nucleus. Together, Lats2 and ASPP1 shunt p53 to proapoptotic promoters and promote the death of polyploid cells. These effects are overridden by the Yap1 (Yes-associated protein 1) oncoprotein, which disrupts Lats2-ASPP1 binding and antagonizes the tumor-suppressing function of the Lats2/ASPP1/p53 axis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041410      PMCID: PMC2964752          DOI: 10.1101/gad.1954410

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  42 in total

1.  Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia.

Authors:  A Jiménez-Velasco; J Román-Gómez; X Agirre; M Barrios; G Navarro; I Vázquez; F Prósper; A Torres; A Heiniger
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

2.  ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.

Authors:  X Agirre; J Román-Gómez; A Jiménez-Velasco; L Garate; C Montiel-Duarte; G Navarro; I Vázquez; M Zalacain; M J Calasanz; A Heiniger; A Torres; J D Minna; F Prósper
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

3.  Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.

Authors:  Michael Overholtzer; Jianmin Zhang; Gromoslaw A Smolen; Beth Muir; Wenmei Li; Dennis C Sgroi; Chu-Xia Deng; Joan S Brugge; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

4.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

Review 5.  BH3-only proteins in cell death initiation, malignant disease and anticancer therapy.

Authors:  V Labi; M Erlacher; S Kiessling; A Villunger
Journal:  Cell Death Differ       Date:  2006-04-28       Impact factor: 15.828

6.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence.

Authors:  Jennifer S Tront; Barbara Hoffman; Dan A Liebermann
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

8.  Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.

Authors:  Yuri Takahashi; Yasuo Miyoshi; Chie Takahata; Natsumi Irahara; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  Clin Cancer Res       Date:  2005-02-15       Impact factor: 12.531

9.  Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.

Authors:  Ze-Jun Liu; Xin Lu; Yun Zhang; Shan Zhong; Shou-Zhi Gu; Xiao-Bing Zhang; Xin Yang; Hai-Ming Xin
Journal:  FEBS Lett       Date:  2005-03-14       Impact factor: 4.124

10.  The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo.

Authors:  J K Thornton; C Dalgleish; J P Venables; K A Sergeant; I E Ehrmann; X Lu; P T K Saunders; D J Elliott
Journal:  Oncogene       Date:  2006-05-25       Impact factor: 9.867

View more
  51 in total

1.  An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.

Authors:  Arnaud M Vigneron; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

2.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

3.  Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation.

Authors:  Kun Zhang; Eva Rodriguez-Aznar; Norikazu Yabuta; Robert J Owen; Jose M Mingot; Hiroshi Nojima; M Angela Nieto; Gregory D Longmore
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

4.  YAP tips the balance.

Authors:  Mhairi Skinner
Journal:  Nat Rev Cancer       Date:  2010-12       Impact factor: 60.716

5.  An identity crisis for a cancer gene: subcellular location determines ASPP1 function.

Authors:  James J Manfredi
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

6.  Hippo signaling: to die or not to die.

Authors:  R I Aqeilan
Journal:  Cell Death Differ       Date:  2013-10       Impact factor: 15.828

7.  Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.

Authors:  Arnaud M Vigneron; Robert L Ludwig; Karen H Vousden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

8.  Contribution of LATS1 and LATS2 promoter methylation in OSCC development.

Authors:  Mohammad Ayoub Rigi Ladiz; Maryam Najafi; Dor Mohammad Kordi-Tamandani
Journal:  J Cell Commun Signal       Date:  2016-10-19       Impact factor: 5.782

9.  A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.

Authors:  Karen S Yee; Lukasz Grochola; Garth Hamilton; Anna Grawenda; Elisabeth E Bond; Helge Taubert; Peter Wurl; Gareth L Bond; Eric O'Neill
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

Review 10.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.